CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer

Abstract Distant metastasis is a significant hallmark affecting to the high death rate of patients with triple-negative breast cancer (TNBC). Thus, it is crucial to identify and develop new therapeutic strategies to hinder cancer metastasis. While emerging studies have hinted a pivotal role of gluco...

Full description

Saved in:
Bibliographic Details
Main Authors: Hye-Youn Kim, Young-Mi Kim, Suntaek Hong
Format: Article
Language:English
Published: Nature Publishing Group 2024-04-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-024-01956-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850197556327350272
author Hye-Youn Kim
Young-Mi Kim
Suntaek Hong
author_facet Hye-Youn Kim
Young-Mi Kim
Suntaek Hong
author_sort Hye-Youn Kim
collection DOAJ
description Abstract Distant metastasis is a significant hallmark affecting to the high death rate of patients with triple-negative breast cancer (TNBC). Thus, it is crucial to identify and develop new therapeutic strategies to hinder cancer metastasis. While emerging studies have hinted a pivotal role of glucose-regulated protein 94 (GRP94) in tumorigenesis, the exact biological functions and molecular mechanisms of GRP94 in modulating cancer metastasis remain to be elucidated. Our study demonstrated an increased expression of GRP94 in TNBC correlated with metastatic progression and unfavorable prognosis in patients. Functionally, we identified that GRP94 depletion significantly diminished TNBC tumorigenesis and subsequent lung metastasis. In contrast, GRP94 overexpression exacerbated the invasiveness, migration, and lung metastasis of non-TNBC cells. Mechanistically, we found that casein kinase 2 alpha (CK2α) active in advanced breast cancer phosphorylated GRP94 at a conserved serine 306 (S306) residue. This phosphorylation increased the stability of GRP94 and enhanced its interaction with LRP6, leading to activation of canonical Wnt signaling. From a therapeutic standpoint, we found that benzamidine, a novel CK2α inhibitor, effectively suppressed GRP94 phosphorylation, LRP6 stabilization, and metastasis of TNBC. Our results point to the critical role of CK2α-mediated GRP94 phosphorylation in TNBC metastasis through activation of Wnt signaling, highlighting GRP94 as a therapeutic target to impede TNBC metastasis.
format Article
id doaj-art-1bbd9316b7a14ce5ad6fa77093c023cb
institution OA Journals
issn 2058-7716
language English
publishDate 2024-04-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-1bbd9316b7a14ce5ad6fa77093c023cb2025-08-20T02:13:07ZengNature Publishing GroupCell Death Discovery2058-77162024-04-0110111410.1038/s41420-024-01956-xCK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancerHye-Youn Kim0Young-Mi Kim1Suntaek Hong2Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of MedicineDepartment of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of MedicineDepartment of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of MedicineAbstract Distant metastasis is a significant hallmark affecting to the high death rate of patients with triple-negative breast cancer (TNBC). Thus, it is crucial to identify and develop new therapeutic strategies to hinder cancer metastasis. While emerging studies have hinted a pivotal role of glucose-regulated protein 94 (GRP94) in tumorigenesis, the exact biological functions and molecular mechanisms of GRP94 in modulating cancer metastasis remain to be elucidated. Our study demonstrated an increased expression of GRP94 in TNBC correlated with metastatic progression and unfavorable prognosis in patients. Functionally, we identified that GRP94 depletion significantly diminished TNBC tumorigenesis and subsequent lung metastasis. In contrast, GRP94 overexpression exacerbated the invasiveness, migration, and lung metastasis of non-TNBC cells. Mechanistically, we found that casein kinase 2 alpha (CK2α) active in advanced breast cancer phosphorylated GRP94 at a conserved serine 306 (S306) residue. This phosphorylation increased the stability of GRP94 and enhanced its interaction with LRP6, leading to activation of canonical Wnt signaling. From a therapeutic standpoint, we found that benzamidine, a novel CK2α inhibitor, effectively suppressed GRP94 phosphorylation, LRP6 stabilization, and metastasis of TNBC. Our results point to the critical role of CK2α-mediated GRP94 phosphorylation in TNBC metastasis through activation of Wnt signaling, highlighting GRP94 as a therapeutic target to impede TNBC metastasis.https://doi.org/10.1038/s41420-024-01956-x
spellingShingle Hye-Youn Kim
Young-Mi Kim
Suntaek Hong
CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
Cell Death Discovery
title CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
title_full CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
title_fullStr CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
title_full_unstemmed CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
title_short CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer
title_sort ck2α mediated phosphorylation of grp94 facilitates the metastatic cascade in triple negative breast cancer
url https://doi.org/10.1038/s41420-024-01956-x
work_keys_str_mv AT hyeyounkim ck2amediatedphosphorylationofgrp94facilitatesthemetastaticcascadeintriplenegativebreastcancer
AT youngmikim ck2amediatedphosphorylationofgrp94facilitatesthemetastaticcascadeintriplenegativebreastcancer
AT suntaekhong ck2amediatedphosphorylationofgrp94facilitatesthemetastaticcascadeintriplenegativebreastcancer